Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling.
Hu WH, Wang HY, Kong XP, Xiong QP, Poon KK, Xu L, Duan R, Chan GK, Dong TT, Tsim KW.
Hu WH, et al.
FASEB J. 2019 Jan;33(1):532-544. doi: 10.1096/fj.201800750R. Epub 2018 Jul 10.
FASEB J. 2019.
PMID: 29989844
The current study provides support for the possible development of polydatin as a potential therapeutic agent for treatment and prevention of angiogenesis-related diseases.-Hu, W.-H., Wang, H.-Y., Kong, X.-P., Xiong, Q.-P., Poon, K. K.-M., Xu, L., Duan, R., C …
The current study provides support for the possible development of polydatin as a potential therapeutic agent for treatment and prevention o …